Bioequivalence Study of Generic Leflunomide 20 mg Film-coated Tablets and Reference Product Under Fasting Conditions - Trial NCT06228443
Access comprehensive clinical trial information for NCT06228443 through Pure Global AI's free database. This Phase 1 trial is sponsored by International Bio service and is currently Not yet recruiting. The study focuses on Healthy Volunteer. Target enrollment is 48 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
International Bio service
Timeline & Enrollment
Phase 1
Apr 01, 2024
Apr 26, 2024
Primary Outcome
Cmax,AUC0-72
Summary
This Study Aims to Assess the Relative Bioavailability, Including the Rate and Extent of
 Absorption, of 20 mg Leflunomide Tablets Compared to ARAVAยฎ 20 mg Tablets. The Evaluation
 Will be Conducted Following a Single Oral Dose (1 x 20 mg Tablet) in Healthy Thai Male
 Volunteers Under Fasting Conditions.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06228443
Non-Device Trial

